Genetic Signatures Limited (ASX:GSS)
Australia
· Delayed Price · Currency is AUD 0.0950
-0.0050 (-5.00%)
At close: Mar 6, 2026
Genetic Signatures Revenue
Genetic Signatures had revenue of 8.68M AUD in the half year ending December 31, 2025, with 140.87% growth. This brings the company's revenue in the last twelve months to 19.94M, up 6.82% year-over-year. In the fiscal year ending June 30, 2025, Genetic Signatures had annual revenue of 19.75M with 43.47% growth.
Revenue (ttm)
19.94M
Revenue Growth
+6.82%
P/S Ratio
1.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 19.75M | 5.99M | 43.47% |
| Jun 30, 2024 | 13.77M | -7.75M | -36.00% |
| Jun 30, 2023 | 21.51M | -13.98M | -39.39% |
| Jun 30, 2022 | 35.50M | 7.11M | 25.06% |
| Jun 30, 2021 | 28.38M | 14.57M | 105.43% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BCAL Diagnostics | 2.54M |
| INOVIQ | 2.10M |
| Microba Life Sciences | 14.90M |
| Imagion Biosystems | 73.03K |
| Rhythm Biosciences | 1.65M |
| Cryosite | 15.75M |
| Genetic Technologies | 9.17M |
| Monash IVF Group | 269.39M |